Join our email list to stay up to date on the latest Amyloidosis news.

ARC is developing a patient-reported outcome (PRO) measurement tool in ATTR amyloidosis to be used to understand and measure the impact of the disease on patients from the patient’s perspective. (more…)

*
*
*








*